Por favor, use este identificador para citar o enlazar este ítem: https://doi.org/10.1016/j.jval.2024.05.004

Título: A feasible estimation of a “corrected” EQ-5D social tariff
Fecha de publicación: 12-jun-2024
Editorial: Elsevier
Cita bibliográfica: Value in Health, 2024. 27(9): 1243-1250
ISSN: Print: 1098-3015
Electronic: 1524-4733
Materias relacionadas: CDU::3 - Ciencias sociales::33 - Economía
Palabras clave: Corrective approach
Debiasing
Health-state utilities
Social tariffs
EQ-5D
Resumen: Objectives: To demonstrate the feasibility of estimating a social tariff free of utility curvature and probability weighting biases and to test transferability between riskless and risky contexts. Methods: Valuations for a selection of EQ-5D-3L health states were collected from a large and representative sample (N = 1676) of the Spanish general population through computer-assisted personal interviewing. Two elicitation methods were used: the traditional time trade-off (TTO) and a novel risky-TTO procedure. Both methods are equivalent for better than death states, which allowed us to test transferability of utilities across riskless and risky contexts. Corrective procedures applied are based on rank-dependent utility theory, identifying parameter estimates at the individual level. All corrections are health-state specific, which is a unique feature of our corrective approach. Results: Two corrected value sets for the EQ-5D-3L system are estimated, highlighting the feasibility of developing national tariffs under nonexpected utility theories, such as rankdependent utility. Furthermore, transferability was not supported for at least half of the health states valued by our sample. Conclusions: It is feasible to estimate a social tariff by using interviewing techniques, sample sizes, and sample representativeness equivalent to prior studies designed to generate national value sets for the EQ-5D. Utilities obtained in distinct contexts may not be interchangeable. Our findings caution against routinely taking transferability of utility for granted.
Autor/es principal/es: Abellán Perpiñán, José María
Martínez Pérez, Jorge Eduardo
Sánchez Martínez, Fernando Ignacio
Pinto Prades, José Luis
Versión del editor: https://www.sciencedirect.com/science/article/pii/S1098301524023647?via%3Dihub
URI: http://hdl.handle.net/10201/147825
DOI: https://doi.org/10.1016/j.jval.2024.05.004
Tipo de documento: info:eu-repo/semantics/article
Número páginas / Extensión: 8
Derechos: info:eu-repo/semantics/openAccess
Atribución 4.0 Internacional
Descripción: © 2024, International Society for Pharmacoeconomics and Outcomes Research, Inc. This manuscript version is made available under the CC-BY 4.0 license http://creativecommons.org/licenses/by/4.0/. This document is the Published version of a Published Work that appeared in final form in Value in Health. To access the final edited and published work see https://doi.org/10.1016/j.jval.2024.05.004.
Matería geográfica: España
Aparece en las colecciones:Artículos

Ficheros en este ítem:
Fichero Descripción TamañoFormato 
Abellan_etal_ValueHealth_2024.pdfArtículo en Value in Health519,99 kBAdobe PDFVista previa
Visualizar/Abrir


Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons Creative Commons